p-SCN-Macropa

Overview

p-SCN-Macropa is a bifunctional macrocyclic chelator featuring macrocyclic polyamine skeletons and thiocyanate (-SCN) reactive moieties. p-SCN-Macropa can conjugate with monoclonal antibodies including Nimotuzumab ( HY-P9968 ), Rituximab ( HY-P9913 ) and Trastuzumab ( HY-P9907 )-PEG6-DM1 for 225 Ac radiolabeling to construct radioimmunoconjugates. p-SCN-Macropa is applicable for the research of colorectal cancer , HER2-positive breast cancer , TROP-2-positive cancers, and PSMA-positive cancers.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Radionuclide-Drug Conjugates (RDCs)

Product Information

• Catalog No.: HY-W1129940
• CAS No.: 2417821-30-6
• Molecular Formula: C35H43N5O9S
• Molecular Weight: 709.81
• Purity: 96.46%
• Storage: -20°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source